The National Times - US Justice Dept taking abortion pill fight to Supreme Court

US Justice Dept taking abortion pill fight to Supreme Court


US Justice Dept taking abortion pill fight to Supreme Court
US Justice Dept taking abortion pill fight to Supreme Court / Photo: © GETTY IMAGES/AFP

The US Justice Department said Thursday that it will go to the Supreme Court to appeal restrictions imposed on a widely-used abortion pill in the latest round of an intensifying battle over reproductive rights.

Change text size:

The decision by President Joe Biden's administration came just hours after an appeals court rejected moves to ban mifepristone outright, but imposed a series of measures restricting access to the pill.

Mifepristone, which was approved by the Food and Drug Administration (FDA) in 2000 and accounts for more than half the abortions in the United States, has become the centerpiece of the country's latest clash over women's reproductive freedom.

Attorney General Merrick Garland said the Justice Department will be "seeking emergency relief from the Supreme Court to defend the FDA's scientific judgment and protect Americans' access to safe and effective reproductive care."

Speaking to reporters during Biden's visit to Dublin, Ireland, White House Press Secretary Karine Jean-Pierre said "we believe that the law is on our side, and we will prevail."

Late Wednesday, the US Fifth Circuit Court of Appeals said mifepristone, also known as RU 486, should remain available pending a full hearing of the case, but limited access to the first seven weeks of pregnancy, down from 10.

The appeals court also said in-person visits would be necessary to obtain the pill -- a requirement lifted in recent years -- and blocked the medication from being sent by mail.

The 2-1 ruling by the conservative-majority appeals court in New Orleans, Louisiana, came after a US District Court judge in Texas overturned the FDA's two-decades old approval of the drug last Friday.

- 'Furious' -

The appeals court said anti-abortion opponents had waited too long to challenge the drug's approval by the FDA but the judges' decision to impose restrictions on its use was denounced by groups seeking to maintain access to abortion.

"We are furious that yet another court would choose to jeopardize the health and futures of the millions of people who rely on mifepristone for abortion care," said Planned Parenthood president Alexis McGill Johnson.

Jennifer Dalven, director of the ACLU Reproductive Freedom Project, said "unless the Supreme Court steps in, this decision will prevent many people from getting abortion care and force them to remain pregnant against their will."

The anti-abortion group Susan B. Anthony described the appeals court ruling by two judges appointed by former Republican president Donald Trump as a "win."

"The court recognized that the abortion pill is dangerous and rolled back Biden's reckless mail-order abortion scheme," said Susan B. Anthony state policy director Katie Daniel. "We look forward to the Supreme Court hearing this case."

The latest standoff over abortion rights comes nearly a year after the Supreme Court, where conservatives wield a 6-3 majority, overturned the landmark Roe v. Wade ruling that had enshrined the constitutional right to abortion for half a century.

Mifepristone is one component of a two-drug regimen that can be used in the United States through the first 10 weeks of pregnancy.

It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.

- 'Unborn human' -

Last week's ruling by Judge Matthew Kacsmaryk, also a Trump appointee, seeking to impose a nationwide ban on mifepristone came in response to a suit by a coalition of anti-abortion groups.

The judge, in his decision, adopted language used by abortion opponents, saying the drug was used to "kill the unborn human."

Kacsmaryk said the two-drug regimen that includes mifepristone had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.

But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective when used as indicated.

The Biden administration and leading pharmaceutical and biotech companies also argued that Kacsmaryk's ruling risked undermining the entire drug approval authority of the FDA.

"If this decision stands, no medication -- from chemotherapy drugs, to asthma medicine, to blood pressure pills, to insulin -- would be safe from attacks," said Vice President Kamala Harris.

Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit access to the procedure -- or ban it outright.

T.F.Russell--TNT

Featured

एलेक्स बोडी और SCANDIC PAY: Mastercard और VISA कार्ड — भुगतान की नई पीढ़ी

ऐसा लगता है कि एलेक्स बोडी दुनिया भर में कारोबार करने वाले SCANDIC समूह में बहुमत हिस्सेदारी रखने वाले शेयरधारक को राज़ी करने में सफल रहे हैं। अपना कार्ड ब्रांड, अंतरराष्ट्रीय खाते और डिजिटल भुगतान सुविधाएँ: SCANDIC PAY / BODI की अवधारणा रोमानियाई उद्यमी एलेक्स बोडी और SCANDIC कंपनी समूह के बीच सहयोग को SNC इकोसिस्टम में एक विशिष्ट पहचान देती है।

ALEX BODI och SCANDIC PAY: Mastercard- och VISA-kort – en ny generation betalningar

Alex Bodi verkar ha lyckats övertyga majoritetsägaren i den globalt verksamma SCANDIC-koncernen. Ett eget kortvarumärke, internationella konton och digitala betalningsfunktioner: med konceptet SCANDIC PAY / BODI får samarbetet mellan den rumänske entreprenören Alex Bodi och SCANDIC-koncernen en tydlig profil inom SNC-ekosystemet.

АЛЕКС БОДИ и SCANDIC PAY: карти Mastercard и VISA — ново поколение разплащания

Изглежда, че Алекс Боди е успял да убеди мажоритарния акционер на групата SCANDIC, която развива дейност в световен мащаб. Собствена марка платежни карти, международни сметки и функции за цифрови плащания: с концепцията SCANDIC PAY / BODI сътрудничеството между румънския предприемач Алекс Боди и групата компании SCANDIC придобива ясно разпознаваем облик в екосистемата SNC.

알렉스 보디와 SCANDIC PAY: Mastercard·VISA 카드를 통한 차세대 결제

알렉스 보디(Alex Bodi)는 전 세계에서 사업을 전개하는 SCANDIC 그룹의 과반 지분을 보유한 주주를 설득하는 데 성공한 것으로 보인다. 자체 카드 브랜드, 국제 계좌, 디지털 결제 기능을 결합한 SCANDIC PAY / BODI 구상은 루마니아 기업가 알렉스 보디와 SCANDIC 기업그룹의 협력을 SNC 생태계 안에서 뚜렷하게 드러낸다. 

Change text size: